FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3150561979> ?p ?o ?g. }

• W3150561979 abstract "Abstract Background Antigen rapid diagnostic tests (RDT) for SARS-CoV-2 are fast, broadly available, and inexpensive. Despite this, reliable clinical performance data is sparse. Methods In a prospective performance evaluation study, RDT from three manufacturers (NADAL®, Panbio™, MEDsan®) were compared to quantitative reverse transcription polymerase chain reaction (RT-qPCR) in 5 068 oropharyngeal swabs for detection of SARS-CoV-2 in a hospital setting. Viral load was derived from standardized RT-qPCR Cycle threshold (C t ) values. The data collection period ranged from November 12, 2020 to February 28, 2021. Findings Overall, sensitivity of RDT compared to RT-qPCR was 42·57% (95% CI 33·38%–52·31%), and specificity 99·68% (95% CI 99·48%–99·80%). Sensitivity declined with decreasing viral load from 100% in samples with a deduced viral load of ≥10 8 SARS-CoV-2 RNA copies per ml to 8·82% in samples with a viral load lower than 10 4 SARS-CoV-2 RNA copies per ml. No significant differences in sensitivity or specificity could be observed between the three manufacturers, or between samples with and without spike protein variant B.1.1.7. The NPV in the study cohort was 98·84%; the PPV in persons with typical COVID-19 symptoms was 97·37%, and 28·57% in persons without or with atypical symptoms. Interpretation RDT are a reliable method to diagnose SARS-CoV-2 infection in persons with high viral load. RDT are a valuable addition to RT-qPCR testing, as they reliably detect infectious persons with high viral loads before RT-qPCR results are available. Funding German Federal Ministry for Education and Science (BMBF), Free State of Bavaria Research in context Evidence before this study We searched PubMED an MedRxiv for articles including “COVID-19”, “COVID”, “SARS-CoV-2”, “coronavirus” as well as “antigen detection”, “rapid antigen test”, “Point-of-Care test” in title or abstract, published between January 1, 2020 and February 28, 2021. The more than 150 RDT on the market at the end of February 2021 represent a huge expansion of diagnostic possibilities. 1 Performance of currently available RDT is evaluated in several international studies, with heterogeneous results. Sensitivity values of RDT range from 0·0% 2 to 98·3% 3 , specificity from 19·4% 4 to 100·0%. 2,5–14 . Some of this data differs greatly from manufacturers’ data. However, these previously published performance evaluation studies were conducted under laboratory conditions using frozen swabs, or in small cohorts with middle-aged participants. Comparable RDT performance data from large-scale clinical usage is missing. 5–19 Added value of this study Based on previous examinations the real life opportunities and limitations of SARS-CoV-2 RDT as an instrument of hospital infection detection and control are still unclear as well as further study results are limited in transferability to general public. Our findings show that RDT performance in daily clinical routine is reliable in persons with high viral for punctual detection and isolation of infectious persons before RT-qPCR become available. In persons with lower viral load, or in case of asymptomatic patients SARS-CoV2 detection by RDT was unsuccessful. The general sensitivity of 42·57% is too low to accept the RDT in clinical use as an alternative to RT-qPCR in diagnosis of COVID-19. Calculated specificity was 99.68%. The results are based on a huge study cohort with more than 5 000 participants including a representative ages structure with pediatric patients up to geriatric individuals, which portrays approximately the demographic structure of the local society. Implications of all the available evidence Due to the low general sensitivity RDT in clinical use cannot be accepted as an alternative but as an addition to RT-qPCR in SARS-CoV-2 diagnosis. The benefit of early detection of highly infectious persons has to be seen in context of the effort of testing and isolation of false positive tested persons." @default.
• W3150561979 created "2021-04-13" @default.
• W3150561979 creator A5008249486 @default.
• W3150561979 creator A5012448086 @default.
• W3150561979 creator A5012874027 @default.
• W3150561979 creator A5024265915 @default.
• W3150561979 creator A5039094459 @default.
• W3150561979 creator A5041772630 @default.
• W3150561979 creator A5042469564 @default.
• W3150561979 creator A5044917199 @default.
• W3150561979 creator A5045684759 @default.
• W3150561979 creator A5047730891 @default.
• W3150561979 creator A5052419076 @default.
• W3150561979 creator A5055246449 @default.
• W3150561979 creator A5056468178 @default.
• W3150561979 creator A5061460875 @default.
• W3150561979 creator A5063093435 @default.
• W3150561979 creator A5065249121 @default.
• W3150561979 creator A5078291053 @default.
• W3150561979 creator A5089654280 @default.
• W3150561979 creator A5089905528 @default.
• W3150561979 creator A5090126757 @default.
• W3150561979 date "2021-03-29" @default.
• W3150561979 modified "2023-09-27" @default.
• W3150561979 title "Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR" @default.
• W3150561979 cites W3001195213 @default.
• W3150561979 cites W3011420630 @default.
• W3150561979 cites W3013893137 @default.
• W3150561979 cites W3015061143 @default.
• W3150561979 cites W3038042287 @default.
• W3150561979 cites W3090114246 @default.
• W3150561979 cites W3092561095 @default.
• W3150561979 cites W3093357954 @default.
• W3150561979 cites W3094416276 @default.
• W3150561979 cites W3099298594 @default.
• W3150561979 cites W3101012525 @default.
• W3150561979 cites W3102935294 @default.
• W3150561979 cites W3105868609 @default.
• W3150561979 cites W3107300730 @default.
• W3150561979 cites W3110328414 @default.
• W3150561979 cites W3111216988 @default.
• W3150561979 cites W3111570571 @default.
• W3150561979 cites W3112533039 @default.
• W3150561979 cites W3113344489 @default.
• W3150561979 cites W3115366018 @default.
• W3150561979 cites W3116503590 @default.
• W3150561979 cites W3120052220 @default.
• W3150561979 cites W3120148919 @default.
• W3150561979 cites W3120311823 @default.
• W3150561979 cites W3121365103 @default.
• W3150561979 cites W3124621456 @default.
• W3150561979 cites W3127602500 @default.
• W3150561979 cites W3129880731 @default.
• W3150561979 doi "https://doi.org/10.1101/2021.03.27.21253966" @default.
• W3150561979 hasPublicationYear "2021" @default.
• W3150561979 type Work @default.
• W3150561979 sameAs 3150561979 @default.
• W3150561979 citedByCount "3" @default.
• W3150561979 countsByYear W31505619792021 @default.
• W3150561979 countsByYear W31505619792022 @default.
• W3150561979 crossrefType "posted-content" @default.
• W3150561979 hasAuthorship W3150561979A5008249486 @default.
• W3150561979 hasAuthorship W3150561979A5012448086 @default.
• W3150561979 hasAuthorship W3150561979A5012874027 @default.
• W3150561979 hasAuthorship W3150561979A5024265915 @default.
• W3150561979 hasAuthorship W3150561979A5039094459 @default.
• W3150561979 hasAuthorship W3150561979A5041772630 @default.
• W3150561979 hasAuthorship W3150561979A5042469564 @default.
• W3150561979 hasAuthorship W3150561979A5044917199 @default.
• W3150561979 hasAuthorship W3150561979A5045684759 @default.
• W3150561979 hasAuthorship W3150561979A5047730891 @default.
• W3150561979 hasAuthorship W3150561979A5052419076 @default.
• W3150561979 hasAuthorship W3150561979A5055246449 @default.
• W3150561979 hasAuthorship W3150561979A5056468178 @default.
• W3150561979 hasAuthorship W3150561979A5061460875 @default.
• W3150561979 hasAuthorship W3150561979A5063093435 @default.
• W3150561979 hasAuthorship W3150561979A5065249121 @default.
• W3150561979 hasAuthorship W3150561979A5078291053 @default.
• W3150561979 hasAuthorship W3150561979A5089654280 @default.
• W3150561979 hasAuthorship W3150561979A5089905528 @default.
• W3150561979 hasAuthorship W3150561979A5090126757 @default.
• W3150561979 hasBestOaLocation W31505619791 @default.
• W3150561979 hasConcept C104317684 @default.
• W3150561979 hasConcept C105580179 @default.
• W3150561979 hasConcept C126322002 @default.
• W3150561979 hasConcept C142462285 @default.
• W3150561979 hasConcept C147483822 @default.
• W3150561979 hasConcept C159047783 @default.
• W3150561979 hasConcept C203014093 @default.
• W3150561979 hasConcept C2522874641 @default.
• W3150561979 hasConcept C2779134260 @default.
• W3150561979 hasConcept C3007834351 @default.
• W3150561979 hasConcept C3008058167 @default.
• W3150561979 hasConcept C4692481 @default.
• W3150561979 hasConcept C48023723 @default.
• W3150561979 hasConcept C524204448 @default.
• W3150561979 hasConcept C55493867 @default.
• W3150561979 hasConcept C64841741 @default.
• W3150561979 hasConcept C71924100 @default.
• W3150561979 hasConcept C86803240 @default.

• next